Johnson & Johnson has agreed to acquire autoimmune disease specialist Momenta Pharmaceuticals in an all-cash transaction of about $6.5 billion. Both companies’ boards of...
04.08.2012
- A divided federal appeals court overturned an order in favor of Momenta Pharmaceuticals that had blocked Watson Pharmaceuticals from selling a generic version of the blood-thinning...
